alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › cognitive-decline

cognitive-decline

14 studies tagged cognitive-decline, dated 2014-06-23 to 2024-12-23. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China 2024-12-23
  2. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers 2024-06-22
  3. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study 2024-05-16

Studies

14 studies carry this tag.

Date range

2014 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 3
  • Scientific reports 2
  • Alzheimer's research & therapy 1
  • Annals of neurology 1
  • Brain communications 1

11 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-23 Biomarkers

    The common and distinct risk factors across cognitive decline stages emphasize the need for tailored interventions.

  2. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Cells 2024-06-22 Biomarkers

    This prospective cohort study revealed that plasma NFL may predict longitudinal declines in Mini-Mental State Examination (MMSE) scores.

  3. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-05-16 Biomarkers

    These relatively non-invasive tests may be beneficial for clinical screening after replication in other populations and validation through neuroimaging or cerebrospinal fluid analysis.

  4. Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Journal of Alzheimer's disease : JAD 2024-01-01 Biomarkers

    Our findings suggest that blood-based biomarkers of AD-related pathology predict cognitive decline in patients with cardiovascular diseases.

  5. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-12-17 Biomarkers

    GFAP, NfL, and p-tau181 are valuable predictors of cognition and function across common neurodegenerative diseases, and may be useful in specialized clinics and clinical trials.

  6. Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Brain communications 2023-06-13 Biomarkers

    Relative to controls, greater Alzheimer's disease pathology (lower amyloid-β 42 /amyloid-β 40 , higher phosphorylated-tau-181) and synaptic degeneration (neurogranin) biomarker concentrations were associated with more adverse white matter metrics (e.g. lower neurite density, higher mean diffusivity) in patients with asthma.

  7. Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Neurobiology of aging 2022-08-17 Biomarkers

    Although liver dysfunction has been implicated in Alzheimer's disease (AD), it remains unknown how liver disease may influence the trajectory of brain and cognitive changes in older adults.

  8. Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Annals of neurology 2022-06-07 Biomarkers

    An easily obtained plasma-based predictor identifies individuals with PD at risk for cognitive decline.

  9. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Science advances 2022-04-01 Biomarkers

    CD22 has been suggested to contribute to Alzheimer's disease (AD) pathogenesis by inhibiting microglial amyloid β (Aβ) phagocytosis.

  10. Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Frontiers in aging neuroscience 2021-05-28 Biomarkers

    The rate of cognitive decline among patients with amnestic mild cognitive impairment (aMCI) varies, and it is thus crucial to accurately predict the probability of cognitive deterioration in patients with MCI.

  11. NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Scientific reports 2021-05-13 Biomarkers

    Peripheral inflammation mechanisms involved in Alzheimer's disease (AD) have yet to be accurately characterized and the identification of blood biomarker profiles could help predict cognitive decline and optimize patient care.

  12. Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Scientific reports 2021-03-29 Biomarkers

    Cerebral microbleeds (MBs) have been found in patients with cognitive decline.

  13. The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Frontiers in neurology 2020-03-06 Biomarkers

    We examined the effects of a dihydropyridine calcium channel blocker nilvadipine with anti-inflammatory properties on cognition and cerebrospinal fluid (CSF) biomarkers by baseline Alzheimer's disease (AD) severity.

  14. Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's research & therapy 2014-06-23 Biomarkers

    Our study confirms a lack of suitability of CSF C3 and FH as diagnostic biomarkers of AD, but points to their modest potential as prognostic biomarkers and therapeutic targets in cognitively impaired patients.

All topic tags with their study counts